2005 photo from Jeff's school year book.. thanx to MSNBC
![]() |
| "The following side effects arc listed for Prozac: apathy, hallucinations, hostility, irrational ideas, paranoid reactions, antisocial behavior, hysteria, and suicidal thoughts." An explosive cocktail of symptoms." ( BUT ALSO the ability to neuologically make contact with the reptilian house of SATAN!.. ) |
![]() |
PROZAC.. ( notice the polyethylene glycol was created by IG FARBEN- highly toxic)
http://www.chem.ox.ac.uk/mom/porzac/default.html/
| Fluoxetine hydrochloride is an antidepressant
for oral administration; it is chemically
unrelated to tricyclic, tetracyclic, or other available
antidepressant agents. It is designated
(±)-N-methyl-3-phenyl-3-[(a,aa-trifluoro-p-tolyl)-oxy]propylamine
hydrochloride and has the empirica formula of
C17H18F3NOxHCl. Its molecular weight is 345.79. Fluoxetine hydrochloride is a white to off-white crystallinesolid with a solubility of 14 mg/ml in water. Each Prozac Pulvule contains
fluoxetine hydrochloride equivalent to 10
mg (32.3 mcmol), 20 mg (64.7 mcmol), or 40 mg (129.3 mmol)
of fluoxetine. The Pulvules also contain starch, gelatin,
silicone, titanium dioxide, iron dioxide, and other
inactive ingredients. The 10 mg and 20 mg Pulvules also
contain FD&C blue no. 1, and the 40 mg Pulvule also
contains FD&C blueno. 1 and FD&C yellow no. 6. Each Prozac tablet contains
fluoxetine HCl equivalent to 10 mg (32.3 mmol) of
fluoxetine. The tablets also contain microcrystalline
cellulose, magnesium stearate, crospovidone,
hydroxypropyl methylcellulose, titanium dioxide,
polyethylene glycol, and yellow iron oxide. In addition
to the above ingredients, the 10 mg tablet contains
FD&C blue no. 1 aluminum lake, and polysorbate 80. |
THIS NEXT PHOTO IS CYAN BLUE FILTER WITH SOLARIZED FINDING EDGES>>
Jeff is quite HUMAN .. however.......scroll down more
![]() |
![]() |
![]() |
![]() |
Dr. Martin Teicher, whose early 1990xs studies linked Prozac to akathisia and suicide, is a co-inventor of the new Prozac, along with Timothy J. Barberich, the CEO of Sepracor Inc., (a Marlborough drug company), and James W. Young. They filed their patent in August 1993, the same year Teicher published "Antidepressant Drugs and the Emergence of Suicidal Tendenciesx, which concluded that patients on Prozac were at least three times more likely to become suicidal than those on older antidepressants. (Journal Drug Safety) |